CO5270017A1 - Prevencion de ruptura de placa por inhibidores acat - Google Patents
Prevencion de ruptura de placa por inhibidores acatInfo
- Publication number
- CO5270017A1 CO5270017A1 CO00083934A CO00083934A CO5270017A1 CO 5270017 A1 CO5270017 A1 CO 5270017A1 CO 00083934 A CO00083934 A CO 00083934A CO 00083934 A CO00083934 A CO 00083934A CO 5270017 A1 CO5270017 A1 CO 5270017A1
- Authority
- CO
- Colombia
- Prior art keywords
- prevention
- acat inhibitors
- plate rupture
- mammal
- rupture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
Un método para inhibir la acumulación de monocitomacrófago en lesiones ateroscleróticas en un mamífero, incluyendo al ser humano, que necesita de tal tratamiento que comprende la administración a dicho mamífero de una cantidad terapéuticamente efectiva de un inhibidor ACAT.<EMI FILE="00083934_1" ID="1" IMF=JPEG >
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16381499P | 1999-11-05 | 1999-11-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5270017A1 true CO5270017A1 (es) | 2003-04-30 |
Family
ID=22591694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00083934A CO5270017A1 (es) | 1999-11-05 | 2000-11-03 | Prevencion de ruptura de placa por inhibidores acat |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1229907A1 (es) |
JP (1) | JP2003513909A (es) |
KR (1) | KR20020050257A (es) |
CN (1) | CN1414848A (es) |
AR (1) | AR026354A1 (es) |
AU (1) | AU1210401A (es) |
CA (1) | CA2382676A1 (es) |
CO (1) | CO5270017A1 (es) |
GT (1) | GT200000193A (es) |
HU (1) | HUP0203160A3 (es) |
IL (1) | IL149145A0 (es) |
PA (1) | PA8506101A1 (es) |
PE (1) | PE20011027A1 (es) |
PL (1) | PL355148A1 (es) |
SV (1) | SV2001000207A (es) |
TR (1) | TR200201204T2 (es) |
UY (1) | UY26427A1 (es) |
WO (1) | WO2001034127A1 (es) |
ZA (1) | ZA200201755B (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2358734C2 (ru) | 2003-08-29 | 2009-06-20 | Кова Ко., Лтд. | Способ стабилизации бляшки с высоким содержанием липидов и способ профилактики ее разрушения |
JP2007532617A (ja) * | 2004-04-15 | 2007-11-15 | アテラ バイオテクノロジーズ エービー | アテローム血栓症およびプラーク破壊を予防するためのアネキシンv |
NZ608903A (en) | 2010-11-03 | 2014-06-27 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
AU2012329045A1 (en) | 2011-10-26 | 2014-04-17 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
US9708288B2 (en) | 2012-04-27 | 2017-07-18 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
US9282739B2 (en) | 2012-04-27 | 2016-03-15 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
US20130291227A1 (en) | 2012-04-27 | 2013-10-31 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
CA2925873A1 (en) | 2013-10-17 | 2015-04-23 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
MX2016004942A (es) | 2013-10-17 | 2016-06-28 | Dow Agrosciences Llc | Procesos para la preparacion de compuestos plaguicidas. |
US9029554B1 (en) | 2013-10-17 | 2015-05-12 | Dow Agrosciences Llc | Processes for the preparation of pesticidal compounds |
BR112016007518A2 (pt) | 2013-10-17 | 2017-08-01 | Dow Agrosciences Llc | processos para a preparação de compostos pesticidas |
JP6487426B2 (ja) | 2013-10-17 | 2019-03-20 | ダウ アグロサイエンシィズ エルエルシー | 有害生物防除化合物の調製法 |
CN105636442B (zh) | 2013-10-17 | 2018-04-27 | 美国陶氏益农公司 | 制备杀虫化合物的方法 |
EP3057428A4 (en) | 2013-10-17 | 2017-05-17 | Dow AgroSciences LLC | Processes for the preparation of pesticidal compounds |
CN105792652A (zh) | 2013-10-22 | 2016-07-20 | 美国陶氏益农公司 | 协同杀虫组合物和相关方法 |
US9295260B2 (en) | 2013-10-22 | 2016-03-29 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
TW201517797A (zh) | 2013-10-22 | 2015-05-16 | Dow Agrosciences Llc | 協同性殺蟲組成物及相關方法(十一) |
US9474276B2 (en) | 2013-10-22 | 2016-10-25 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
US9801383B2 (en) | 2013-10-22 | 2017-10-31 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
WO2015061140A1 (en) | 2013-10-22 | 2015-04-30 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
JP2016535739A (ja) | 2013-10-22 | 2016-11-17 | ダウ アグロサイエンシィズ エルエルシー | 農薬組成物および関連する方法 |
MX2016005317A (es) | 2013-10-22 | 2016-08-12 | Dow Agrosciences Llc | Composiciones pesticidas y metodos relacionados. |
RU2016119368A (ru) | 2013-10-22 | 2017-11-28 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Синергетические пестицидные композиции и связанные с ними способы |
NZ719754A (en) | 2013-10-22 | 2017-06-30 | Dow Agrosciences Llc | Synergistic pesticidal compositions and related methods |
AR098096A1 (es) | 2013-10-22 | 2016-05-04 | Dow Agrosciences Llc | Composiciones plaguicidas sinérgicas y métodos relacionados |
JP2016535024A (ja) | 2013-10-22 | 2016-11-10 | ダウ アグロサイエンシィズ エルエルシー | 相乗的有害生物防除組成物および関連する方法 |
NZ719688A (en) | 2013-10-22 | 2017-06-30 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
KR20160074582A (ko) | 2013-10-22 | 2016-06-28 | 다우 아그로사이언시즈 엘엘씨 | 상승작용적 살충 조성물 및 관련 방법 |
WO2015061163A1 (en) | 2013-10-22 | 2015-04-30 | Dow Agrosciences Llc | Pesticidal compositions and related methods |
JP2016538266A (ja) | 2013-10-22 | 2016-12-08 | ダウ アグロサイエンシィズ エルエルシー | 相乗的有害生物防除組成物および関連する方法 |
MX2016005323A (es) | 2013-10-22 | 2016-08-12 | Dow Agrosciences Llc | Composiciones pesticidas y metodos relacionados. |
KR20170038785A (ko) | 2014-07-31 | 2017-04-07 | 다우 아그로사이언시즈 엘엘씨 | 3-(3-클로로-1h-피라졸-1-일)피리딘의 제조 방법 |
BR112017000565A2 (pt) | 2014-07-31 | 2017-11-07 | Dow Agrosciences Llc | processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina |
JP2017523168A (ja) | 2014-07-31 | 2017-08-17 | ダウ アグロサイエンシィズ エルエルシー | 3−(3−クロロ−1h−ピラゾール−1−イル)ピリジンの製造方法 |
WO2016028328A1 (en) | 2014-08-19 | 2016-02-25 | Dow Agrosciences Llc | Process for the preparation of 3-(3-chloro-1h-pyrazol-1-yl)pyridine |
US9085552B1 (en) | 2014-09-12 | 2015-07-21 | Dow Agrosciences Llc | Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine |
EP3209671B8 (en) * | 2014-10-21 | 2019-07-31 | Council of Scientific and Industrial Research | Alkylidene phosphonate esters as p-glycoprotein inducers |
PE20190656A1 (es) * | 2016-07-29 | 2019-05-08 | Lupin Ltd | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 |
WO2018093966A1 (en) | 2016-11-16 | 2018-05-24 | Purdue Research Foundation | Compositions and methods for regulating body weight and metabolic syndromes |
US10233155B2 (en) | 2016-12-29 | 2019-03-19 | Dow Agrosciences Llc | Processes for the preparation of pesticide compounds |
CN110139853B (zh) | 2016-12-29 | 2023-06-16 | 美国陶氏益农公司 | 用于制备杀有害生物化合物的方法 |
AU2018354777A1 (en) | 2017-10-27 | 2020-04-16 | Bayer Aktiengesellschaft | Novel Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors |
WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU654688B2 (en) * | 1990-10-30 | 1994-11-17 | Warner-Lambert Company | Oxysulfonyl carbamates |
IL109431A (en) * | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
IT1270976B (it) * | 1993-08-06 | 1997-05-26 | Pierrel Spa | Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono |
JPH11510184A (ja) * | 1995-08-04 | 1999-09-07 | ワーナー−ランバート・コンパニー | リポ蛋白レベルを低下させるための医薬の製造用スルファミン酸誘導体、アシルスルホンアミドまたはスルホニルカルバメートの使用 |
CN1217656C (zh) * | 1995-11-02 | 2005-09-07 | 沃尼尔·朗伯公司 | 用于调节脂浓度的方法和药物组合物 |
IL140982A0 (en) * | 1998-07-21 | 2002-02-10 | Warner Lambert Co | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
-
2000
- 2000-10-17 CN CN00812939A patent/CN1414848A/zh active Pending
- 2000-10-17 TR TR2002/01204T patent/TR200201204T2/xx unknown
- 2000-10-17 HU HU0203160A patent/HUP0203160A3/hu unknown
- 2000-10-17 PL PL00355148A patent/PL355148A1/xx not_active Application Discontinuation
- 2000-10-17 EP EP00973608A patent/EP1229907A1/en not_active Withdrawn
- 2000-10-17 IL IL14914500A patent/IL149145A0/xx unknown
- 2000-10-17 KR KR1020027005801A patent/KR20020050257A/ko not_active Application Discontinuation
- 2000-10-17 CA CA002382676A patent/CA2382676A1/en not_active Abandoned
- 2000-10-17 JP JP2001536127A patent/JP2003513909A/ja active Pending
- 2000-10-17 AU AU12104/01A patent/AU1210401A/en not_active Abandoned
- 2000-10-17 WO PCT/US2000/028705 patent/WO2001034127A1/en not_active Application Discontinuation
- 2000-10-25 SV SV2000000207A patent/SV2001000207A/es unknown
- 2000-11-01 PA PA20008506101A patent/PA8506101A1/es unknown
- 2000-11-03 PE PE2000001173A patent/PE20011027A1/es not_active Application Discontinuation
- 2000-11-03 UY UY26427A patent/UY26427A1/es not_active Application Discontinuation
- 2000-11-03 AR ARP000105803A patent/AR026354A1/es unknown
- 2000-11-03 CO CO00083934A patent/CO5270017A1/es not_active Application Discontinuation
- 2000-11-03 GT GT200000193A patent/GT200000193A/es unknown
-
2002
- 2002-03-01 ZA ZA200201755A patent/ZA200201755B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20020050257A (ko) | 2002-06-26 |
PA8506101A1 (es) | 2002-10-28 |
ZA200201755B (en) | 2003-08-27 |
PL355148A1 (en) | 2004-04-05 |
GT200000193A (es) | 2002-04-27 |
WO2001034127A1 (en) | 2001-05-17 |
AR026354A1 (es) | 2003-02-05 |
HUP0203160A2 (hu) | 2003-01-28 |
AU1210401A (en) | 2001-06-06 |
IL149145A0 (en) | 2002-11-10 |
HUP0203160A3 (en) | 2006-02-28 |
CA2382676A1 (en) | 2001-05-17 |
SV2001000207A (es) | 2001-10-16 |
PE20011027A1 (es) | 2001-10-16 |
CN1414848A (zh) | 2003-04-30 |
UY26427A1 (es) | 2000-12-29 |
TR200201204T2 (tr) | 2002-08-21 |
JP2003513909A (ja) | 2003-04-15 |
EP1229907A1 (en) | 2002-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5270017A1 (es) | Prevencion de ruptura de placa por inhibidores acat | |
CO5280216A1 (es) | Tratamiento de la enfermendad neurodegenerativa | |
CO5690131A1 (es) | Derivados de eter biarilico que presentan actividad como inhibidores de la recaptacion de monoaminas para el tratamiento de transtornos del snc | |
AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
ES2196190T3 (es) | Inhibidores de metaloproteinasas matriciales, con hidroxamato bifenlico. | |
EP0919234A3 (en) | Potentiation of pharmaceuticals by moxonidine | |
CO5570109A1 (es) | Compuestos de dihidropirimidina heterociclicos | |
AR064895A2 (es) | Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina | |
AR052221A1 (es) | Metodo para el tratamiento de la enfermedad poliquistosis renal | |
DK1216038T3 (da) | Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
ES2188177T3 (es) | Composicion para la prevencion y/o el tratamiento de la osteoporosis y las alteraciones debidas al sindrome menopausico, que comprende propionil-l-carnitina y genisteina. | |
AP2002002703A0 (en) | Combinations of depeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diadetes mellitus. | |
BR0211274A (pt) | Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase | |
WO2001070212A3 (en) | Method and composition for preventing or reducing the symptoms of menopause | |
BR9914163A (pt) | Agente para melhorar a potência excretora da bexiga urinária, uso de um composto de amina do tipo não carbamato que tenha uma ação inibidora de acetilcolinesterase, e, método para melhorar a potência excretora da bexiga urinária | |
CO5261493A1 (es) | Procedimiento y compuestos para la inhibicion de la mrp1 | |
CO5070569A1 (es) | Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen | |
WO2002015921A3 (en) | Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor | |
CO5271724A1 (es) | Uso de agonistas de prostaglandinas para tratar la disfuncion erectil o la impotencia | |
CO5570661A2 (es) | Combinaciones que comprenden inhibidores de cox-2 y aspirina | |
CO5160295A1 (es) | Nuevas combinaciones farmaceuticas para inhibidores de la nos cionalmente un ssri | |
CO5150193A1 (es) | DIHIDROXIACIDO ABIERTO Y SALES DE INHIBIDORES DE LA HMG-CoA REDUCTASA | |
CO5200850A1 (es) | Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion | |
CO5150166A1 (es) | (s)-10, 11-dihidro-3[2-(5,6,7,8-tetrahidro-1,8-naftiridin -2-il)-etoxi]-5h-dibenzo [a,d] cicloheptano-10-acido acetico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |